Pathstone Holdings »

Krystal Biotech shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $919k 5.0k 182.03

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Coca-Cola Company (KO)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Krystal Biotech

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Frazier Life Sciences Management
Capital World Investors
Redmile Group
Dimensional Fund Advisors
Geode Capital Management
Susquehanna International
T. Rowe Price Associates
Goldman Sachs Group
Jennison Associates
Invesco
Nuveen Asset Management

View all funds holding Krystal Biotech